CTCs + CEA + CYFRA21-1 + NSE

Biomarker

1 finding

“The combined diagnostic sensitivity of CTCs, CEA, CYFRA21-1, and NSE reached 86.05%, with 100.00% specificity and an AUC of 0.945.”
Clinical value of CTCs combined with serum tumor markers/inflammatory cytokines for the early diagnosis of non-small cell lung cancerImmunobiology2026doi:10.1016/j.imbio.2026.153161

Associations

1

Non-small cell lung cancer

upin humans1

1 study
  1. CTCs + CEA + CYFRA21-1 + NSE predicts non-small cell lung cancer in humans (diagnosis of early-stage NSCLC) (AUC 0.945, sensitivity 86.05%, specificity 100.00%).

    Humansdiagnosis of early-stage NSCLCblood

More on Non-small cell lung cancer